FDA OKs Labcorp's over-the-counter COVID-19, RSV, flu test

2016 09 02 09 36 05 93 Fda Logo V2 400

The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Labcorp for the first nonprescription test that can detect COVID-19, respiratory syncytial virus (RSV), and influenza A and B.

The Labcorp Seasonal Respiratory Virus RT-PCR DTC (real time-polymerase chain reaction direct-to-consumer) test can detect and differentiate between the three respiratory viruses. It is authorized for at-home sample collection with testing performed in a lab. Results are delivered through an online portal, with follow-up from a healthcare provider for positive results.

The kit can be purchased online or in a store without a prescription.

Page 1 of 8
Next Page